BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9561876)

  • 1. Myocardial viability: known and unknown.
    Bax JJ; Poldermans D; Rambaldi R; Valkema R; Slavich GA; Fioretti PM
    G Ital Cardiol; 1998 Mar; 28(3):229-36. PubMed ID: 9561876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of myocardial viability in ischemic cardiomyopathy.
    Bax JJ
    Heart Lung Circ; 2005; 14 Suppl 2():S8-13. PubMed ID: 16352289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of myocardial viability in chronic ischemic heart disease: current status.
    Rizzello V; Poldermans D; Bax JJ
    Q J Nucl Med Mol Imaging; 2005 Mar; 49(1):81-96. PubMed ID: 15724138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rest-injected 201thallium in the evaluation of myocardial viability.
    Perrone-Filardi P; Dellegrottaglie S; Chiariello M
    Cardiologia; 1999 Jun; 44(6):515-20. PubMed ID: 10443052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial hibernation: a noninvasive physician's point of view.
    Bonow RO
    Ital Heart J; 2002 May; 3(5):285-90. PubMed ID: 12066559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial viability in ischemic heart disease: new directions and perspectives.
    Previtali M
    Ital Heart J; 2001 Feb; 2(2):93-9. PubMed ID: 11256549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of myocardial viability in ischemic heart disease by cardiac magnetic resonance imaging.
    Muellerleile K; Barmeyer A; Groth M; Lund GK
    Minerva Cardioangiol; 2008 Apr; 56(2):237-49. PubMed ID: 18319702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI assessment of myocardial viability: comparison with other imaging techniques.
    Baer FM; Theissen P; Schneider CA; Kettering K; Voth E; Sechtem U; Schicha H
    Rays; 1999; 24(1):96-108. PubMed ID: 10358387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of dobutamine stress echocardiography in myocardial viability.
    Schinkel AF; Poldermans D; Elhendy A; Bax JJ
    Curr Opin Cardiol; 2006 Sep; 21(5):443-9. PubMed ID: 16900006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling.
    Carluccio E; Biagioli P; Alunni G; Murrone A; Giombolini C; Ragni T; Marino PN; Reboldi G; Ambrosio G
    J Am Coll Cardiol; 2006 Mar; 47(5):969-77. PubMed ID: 16516079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose dobutamine echocardiography predicts recovery of left ventricular systolic function following revascularization even in presence of low contractile reserve.
    Kasliwal RR; Paul B; Mustaqueem A; Bansal M; Trehan N
    Indian Heart J; 2006; 58(2):120-5. PubMed ID: 18989055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonstress delayed-enhancement magnetic resonance imaging of the myocardium predicts improvement of function after revascularization for chronic ischemic heart disease with left ventricular dysfunction.
    Schvartzman PR; Srichai MB; Grimm RA; Obuchowski NA; Hammer DF; McCarthy PM; Kasper JM; White RD
    Am Heart J; 2003 Sep; 146(3):535-41. PubMed ID: 12947375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of patients with ischemic cardiomyopathy: the significance of right ventricular function.
    Gureev SV; Kasakov EN; Kormer AY; Ostroumov EN; Shumakov VI
    Heart Surg Forum; 1999; 2(4):330-7. PubMed ID: 11276496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization.
    Penicka M; Tousek P; De Bruyne B; Wijns W; Lang O; Madaric J; Vanderheyden M; Tintera J; Malý M; Widimsky P; Bartunek J
    Eur Heart J; 2007 Jun; 28(11):1366-73. PubMed ID: 17208936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reversible dysfunction of the left ventricle in coronary disease (part two): hibernation and methods for detection of viability].
    Vlahović A; Popović A
    Med Pregl; 2000; 53(3-4):146-53. PubMed ID: 10965679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myocardial viability in man: state of the art and directions to pursue].
    Vanoverschelde JL
    Bull Mem Acad R Med Belg; 1999; 154(1):91-6; discussion 96-8. PubMed ID: 10535159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.
    Mandegar MH; Yousefnia MA; Roshanali F; Rayatzadeh H; Alaeddini F
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):930-6. PubMed ID: 18954632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography and low-dose dobutamine echocardiography in the prediction of postrevascularization improvement in left ventricular function and exercise parameters.
    Wiggers H; Nielsen TT; Bøttcher M; Egeblad H; Bøtker HE
    Am Heart J; 2000 Dec; 140(6):928-36. PubMed ID: 11099997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical applications of cardiac magnetic resonance imaging.
    Pilz G; Heer T; Harrer E; Ali E; Hoefling B
    Minerva Cardioangiol; 2009 Jun; 57(3):299-313. PubMed ID: 19513011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial viability testing in patients with severe left ventricular dysfunction by SPECT and PET.
    Demirkol MO
    Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():60-70. PubMed ID: 19028637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.